Cargando…
Improving the quality of cancer clinical trials : workshop summary /
Scientists and clinicians seek a new paradigm that could improve the efficiency, cost-effectiveness, and overall success rate of cancer clinical trials, while maintaining the highest standards of quality. To explore innovative paradigms for cancer clinical trials and other ways to improve their qual...
| Clasificación: | Libro Electrónico |
|---|---|
| Autores Corporativos: | , |
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Washington, D.C. :
National Academies Press,
©2008.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn560530759 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 080709s2008 dcua ob 000 0 eng d | ||
| 010 | |z 2008299448 | ||
| 040 | |a MERUC |b eng |e pn |c MERUC |d CCO |d E7B |d OCLCQ |d MMU |d N$T |d CDX |d COCUF |d IDEBK |d GPM |d NATAP |d OCLCQ |d OCLCF |d OCLCQ |d NLGGC |d YDXCP |d OCLCQ |d EBLCP |d DEBSZ |d OCLCQ |d AZK |d LOA |d OCLCO |d OCLCA |d TOA |d OCLCO |d AGLDB |d PIFAG |d ZCU |d OCLCO |d OCLCQ |d MERUC |d OCLCO |d OCLCQ |d OCLCO |d U3W |d OCLCA |d BUF |d OCLCO |d STF |d WRM |d OCLCQ |d VTS |d NRAMU |d ICG |d MERER |d CUY |d VT2 |d AU@ |d OCLCQ |d OCLCO |d OCLCA |d LVT |d OCLCQ |d WYU |d TKN |d OCLCO |d DKC |d OCLCO |d OCLCQ |d M8D |d UKAHL |d OCLCQ |d OCLCO |d DST |d OCLCO |d SFB |d OCLCQ |d OCLCO |d OCLCL | ||
| 019 | |a 229459481 |a 248618377 |a 262721048 |a 347009897 |a 646754057 |a 815683887 |a 923278949 |a 961534102 |a 962676638 |a 966110627 |a 991953258 |a 1037906102 |a 1038638975 |a 1039323444 |a 1045494544 |a 1055337098 |a 1058046865 |a 1062893043 |a 1081187943 |a 1082516694 |a 1097095569 |a 1300655730 |a 1303353818 |a 1303516984 | ||
| 020 | |a 9780309116695 |q (electronic bk.) | ||
| 020 | |a 0309116694 |q (electronic bk.) | ||
| 020 | |a 128172680X | ||
| 020 | |a 9781281726803 | ||
| 020 | |z 9780309116688 | ||
| 020 | |z 0309116686 | ||
| 020 | |a 0309178258 | ||
| 020 | |a 9780309178259 | ||
| 020 | |a 9786611726805 | ||
| 020 | |a 6611726802 | ||
| 029 | 1 | |a AU@ |b 000044592878 | |
| 029 | 1 | |a AU@ |b 000051494402 | |
| 029 | 1 | |a AU@ |b 000060546544 | |
| 029 | 1 | |a CDX |b 8842973 | |
| 029 | 1 | |a DEBBG |b BV043170524 | |
| 029 | 1 | |a DEBBG |b BV044108813 | |
| 029 | 1 | |a DEBSZ |b 422108634 | |
| 029 | 1 | |a DEBSZ |b 452575524 | |
| 029 | 1 | |a GBVCP |b 803087535 | |
| 029 | 1 | |a NZ1 |b 14240403 | |
| 035 | |a (OCoLC)560530759 |z (OCoLC)229459481 |z (OCoLC)248618377 |z (OCoLC)262721048 |z (OCoLC)347009897 |z (OCoLC)646754057 |z (OCoLC)815683887 |z (OCoLC)923278949 |z (OCoLC)961534102 |z (OCoLC)962676638 |z (OCoLC)966110627 |z (OCoLC)991953258 |z (OCoLC)1037906102 |z (OCoLC)1038638975 |z (OCoLC)1039323444 |z (OCoLC)1045494544 |z (OCoLC)1055337098 |z (OCoLC)1058046865 |z (OCoLC)1062893043 |z (OCoLC)1081187943 |z (OCoLC)1082516694 |z (OCoLC)1097095569 |z (OCoLC)1300655730 |z (OCoLC)1303353818 |z (OCoLC)1303516984 | ||
| 043 | |a n-us--- | ||
| 050 | 4 | |a RC270.8 |b .I47 2008eb | |
| 060 | 4 | |a QZ 267 |b I34 2008 | |
| 072 | 7 | |a HEA |x 039030 |2 bisacsh | |
| 072 | 7 | |a MJCL |2 bicssc | |
| 082 | 0 | 4 | |a 362.196/994007 |2 22 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Improving the quality of cancer clinical trials : |b workshop summary / |c National Cancer Policy Forum, Margie Patlack and Sharyl Nass, rapporteurs. |
| 260 | |a Washington, D.C. : |b National Academies Press, |c ©2008. | ||
| 300 | |a 1 online resource (xii, 124 pages) : |b illustrations (some color) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file | ||
| 504 | |a Includes bibliographical references. | ||
| 505 | 0 | |a Introduction -- New clinical trial designs. Phase 0 trials -- Adaptive trial designs -- Targeting multiple pathways with multiple drugs -- Preclinical model systems -- Molecular imaging. Current and developing methods -- Challenges of molecular imaging -- Screening for predictive markers. The challenges of clinical validation -- Bioimaging predictive markers -- Clinical translation -- Panel discussion -- Costs of clinical trials. Regulatory costs -- Patient accrual -- Global outsourcing -- Time is money -- Public-private collaborations -- Regulatory issues. Regulatory barriers to innovation -- Patient advocacy perspective -- Regulation of in vitro diagnostics -- Regulatory issues in improving cancer clinical trials -- Reports from the case study discussion groups. Adaptive trial design -- Phase 0 trials -- Imaging -- Use of proteomics/genomics to assign therapy in lung cancer -- Use of genetics/genomics to assign therapy. | |
| 588 | 0 | |a Print version record. | |
| 520 | |a Scientists and clinicians seek a new paradigm that could improve the efficiency, cost-effectiveness, and overall success rate of cancer clinical trials, while maintaining the highest standards of quality. To explore innovative paradigms for cancer clinical trials and other ways to improve their quality, the National Cancer Policy Forum held a workshop, Improving the Quality of Cancer Clinical Trials, in Washington, DC. The main goals of the workshop were to examine new approaches to clinical trial design and execution that would: better inform decisions and plans of those responsible for developing new cancer therapies; more rapidly move new diagnostic tests and treatments toward regulatory approval and use in the clinic; and, be less costly than current trials. The resulting workshop summary will serve as input to the deliberations of an Institute of Medicine committee that will develop consensus-based recommendations for moving the field of cancer clinical trials forward. | ||
| 546 | |a English. | ||
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Cancer |x Treatment |z United States. | |
| 650 | 0 | |a Clinical trials. | |
| 650 | 1 | 2 | |a Neoplasms |x drug therapy |
| 650 | 2 | 2 | |a Clinical Trials as Topic |
| 651 | 2 | |a United States | |
| 650 | 6 | |a Cancer |x Traitement |z États-Unis. | |
| 650 | 6 | |a Études cliniques. | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x Cancer. |2 bisacsh | |
| 650 | 7 | |a Cancer |x Treatment |2 fast | |
| 650 | 7 | |a Clinical trials |2 fast | |
| 651 | 7 | |a United States |2 fast |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq | |
| 700 | 1 | |a Patlak, Margie. | |
| 700 | 1 | |a Nass, Sharyl J. | |
| 710 | 2 | |a National Cancer Policy Forum (U.S.) | |
| 710 | 2 | |a Institute of Medicine (U.S.) | |
| 758 | |i has work: |a Improving the quality of cancer clinical trials (Text) |1 https://id.oclc.org/worldcat/entity/E39PCH7KVwTHb4Dd8bDGgfTgDq |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Improving the quality of cancer clinical trials. |d Washington, D.C. : National Academies Press, ©2008 |w (DLC) 2008299448 |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3378368 |z Texto completo |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36616666 | ||
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36558104 | ||
| 938 | |a Coutts Information Services |b COUT |n 8842973 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL3378368 | ||
| 938 | |a ebrary |b EBRY |n ebr10235163 | ||
| 938 | |a EBSCOhost |b EBSC |n 233565 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n 172680 | ||
| 938 | |a YBP Library Services |b YANK |n 2873886 | ||
| 994 | |a 92 |b IZTAP | ||